UCSF study shows voriconazole increases risk for skin cancer in lung transplant recipients

A study conducted by researchers at the University of California San Francisco (UCSF) has showed that voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant patients, significantly increases the risk of skin can…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news